SCHENA, Francesco Paolo
 Distribuzione geografica
Continente #
NA - Nord America 5.590
AS - Asia 2.354
EU - Europa 1.918
SA - Sud America 562
AF - Africa 102
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 10.538
Nazione #
US - Stati Uniti d'America 5.474
SG - Singapore 945
IT - Italia 569
CN - Cina 531
BR - Brasile 449
SE - Svezia 321
HK - Hong Kong 264
RU - Federazione Russa 240
DE - Germania 195
VN - Vietnam 171
FI - Finlandia 144
FR - Francia 123
GB - Regno Unito 117
BD - Bangladesh 95
IN - India 84
CA - Canada 57
UA - Ucraina 42
BE - Belgio 35
ID - Indonesia 35
AR - Argentina 34
TR - Turchia 33
MX - Messico 32
IQ - Iraq 30
JP - Giappone 26
NL - Olanda 26
ZA - Sudafrica 26
PL - Polonia 25
CI - Costa d'Avorio 24
SA - Arabia Saudita 21
CO - Colombia 20
EC - Ecuador 20
UZ - Uzbekistan 15
PH - Filippine 14
AT - Austria 13
MA - Marocco 12
PK - Pakistan 12
LT - Lituania 11
CZ - Repubblica Ceca 10
ES - Italia 10
IE - Irlanda 10
TN - Tunisia 10
VE - Venezuela 9
MY - Malesia 8
AE - Emirati Arabi Uniti 7
IR - Iran 7
JO - Giordania 7
KE - Kenya 7
PY - Paraguay 7
AU - Australia 6
BO - Bolivia 6
CL - Cile 6
EG - Egitto 6
IL - Israele 6
LB - Libano 6
ET - Etiopia 5
KW - Kuwait 5
CR - Costa Rica 4
DZ - Algeria 4
JM - Giamaica 4
KG - Kirghizistan 4
KZ - Kazakistan 4
PE - Perù 4
TH - Thailandia 4
AO - Angola 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
NI - Nicaragua 3
PT - Portogallo 3
RO - Romania 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CH - Svizzera 2
EE - Estonia 2
EU - Europa 2
GR - Grecia 2
GY - Guiana 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
RS - Serbia 2
SI - Slovenia 2
SR - Suriname 2
SV - El Salvador 2
AQ - Antartide 1
BF - Burkina Faso 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CM - Camerun 1
DM - Dominica 1
GE - Georgia 1
GT - Guatemala 1
Totale 10.524
Città #
Ashburn 631
Fairfield 565
Singapore 494
Chandler 407
San Jose 355
Woodbridge 328
Hong Kong 262
Houston 262
Nyköping 259
Ann Arbor 255
Cambridge 231
Seattle 216
Milan 204
Beijing 172
Wilmington 171
New York 136
Helsinki 104
Los Angeles 95
Dallas 76
Dearborn 75
Jacksonville 75
Lawrence 75
Roxbury 75
Lauterbourg 74
Nanjing 73
Munich 67
Bari 59
Ho Chi Minh City 58
Rome 54
Santa Clara 53
Council Bluffs 48
Des Moines 46
São Paulo 45
Inglewood 39
Hanoi 36
Brooklyn 35
Brussels 34
Columbus 34
Buffalo 31
San Diego 28
Abidjan 24
Chicago 24
Warsaw 24
Boardman 23
Montreal 23
Jakarta 22
Shenyang 21
Tokyo 21
Atlanta 20
Frankfurt am Main 20
Orem 19
Turku 18
Amsterdam 17
London 17
Stockholm 17
Toronto 17
Dong Ket 16
Falkenstein 16
Nanchang 16
Phoenix 16
Hebei 15
Jiaxing 15
Johannesburg 15
Turin 15
Guangzhou 14
San Francisco 14
Nuremberg 13
Princeton 13
Tashkent 13
Boston 12
Chennai 12
Hefei 12
Nashville 12
Paris 12
Rio de Janeiro 12
The Dalles 11
Curitiba 10
Denver 10
Dhaka 10
Mexico City 10
Naples 10
Redwood City 10
Ankara 9
Baghdad 9
Brasília 9
Dublin 9
Figino 9
Guayaquil 9
Ribeirão Preto 9
Biên Hòa 8
Da Nang 8
Kunming 8
Leawood 8
Poplar 8
Pune 8
Riyadh 8
Salt Lake City 8
San Mateo 8
Bitonto 7
Brno 7
Totale 7.147
Nome #
Aberrantly methylated DNA regions lead to low activation of CD4+ T-cells in IgA nephropathy 216
Inhibin-A and Decorin Secreted by Human Adult Renal Stem/Progenitor Cells Through the TLR2 Engagement Induce Renal Tubular Cell Regeneration 212
In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy 207
Altered monocyte expression and expansion of non-classical monocyte subset in IgA nephropathy patients 206
Rapamycin-Induced Hypophosphatemia and Insulin Resistance Are Associated With mTORC2 Activation and Klotho Expression 178
ABNORMAL METHYLATED DNA REGIONS INDICATE AN ATYPICAL RESPONSE OF THE CD4+ T CELLS IN IGA NEPHROPATHY PATIENTS 177
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 169
A transcriptomic study of Hereditary Angioedema attacks 168
Cultivar classification of Apulian olive oils: Use of artificial neural networks for comparing NMR, NIR and merceological data 163
Potential role of effector memory T cells in chronic T cell-mediated kidney graft rejection 156
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool 151
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 147
Clinical Application of Human Urinary Extracellular Vesicles in Kidney and Urologic Diseases 144
Endothelial-to-Mesenchymal Transition (EndMT) in Swine Renal Ischemia Reperfusion (I/R) Injury Is Mediated by Complement and AKT Pathway 143
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab 137
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis 137
Role of let-7b in the regulation of N-acetylgalactosaminyltransferase 2 in IgA nephropathy 136
AQP5: Renal Aquaporins Family Got a New Member 135
Complement-mediated acute induction of endothelial-to-mesenchymal transition (EndMT) in a swine model of renal ischemia/reperfusion (I/R) injury 134
A kinetic test for the assay of the C1 esterase-inhibitor 134
MP065 ABERRANT METHYLATED DNA REGIONS LEAD TO LOW ACTIVATION OF CD4+ T CELLS WITH A CONSEQUENT IMBALANCE OF THE TH1/TH2 POLARIZATION IN IGA NEPHROPATHY PATIENTS 131
Micropatterning control of tubular commitment in human adult renal stem cells 128
Potential Reparative Role of Resident Adult Renal Stem/Progenitor Cells in Acute Kidney Injury 126
Activated Factor X Induces Peripheral Blood Mononuclear Cells Activation During Hemodialysis 124
The three-gene signature in urinary extracellular vesicles from patients with clear cell renal cell carcinoma 123
ADULT RENAL STEM/PROGENITOR CELLS REPAIR ACUTE RENAL TUBULAR CELL INJURY BY MEANS OF SPECIFIC TLR2-DRIVEN PARACRINE FACTORS 123
Activation of NADPH oxidase and coagulation cascade in renal ischemia-reperfusion (I/R) 120
ISCHEMIA AND ISCHEMIA-REPERFUSION (I/R) INDUCE GLOMERULAR AND TUBULAR AKT AND NIK ACTIVATION IN HUMAN (H) AND PIG (P) KIDNEYS 119
COVID-19 and kidney transplantation: an Italian Survey and Consensus 119
Immunosuppressive agents for treating IgA nephropathy 118
ALTERED MONOCYTE GENE EXPRESSION AND EXPANSION OF CD14 (+) CD16 (+) CELL SUBSET IN IgA NEPHROPATHY PATIENTS 117
Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy 116
AKI and stem cells 114
ALPHA-SMOOTH MUSCLE ACTIN (ALPHA-SMA) AND PLATELET-DERIVED GROWTH-FACTOR-BETA RECEPTOR (PDGF-BETA-R) EXPRESSION IN HUMAN-IGA NEPHROPATHY (IGAN) - A TUBULOINTERSTITIAL CORRELATION 111
CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: Role of NF-κB and Lyn 111
A COMBINED MIRNA BIOMARKER FOR NON-INVASIVE DIAGNOSIS OF IDIOPATHIC IGA NEPHROPATHY: AN INTERNATIONAL MULTICENTRE STUDY (NIDIGAN STUDY) 110
RENAL EXPRESSION OF MONOCYTE CHEMOTATIC PROTEIN-1 (MPC-1) AND EPIDERMAL GROW FACTOR (EGF) IN CHILDREN WITH OBDTRUCTIVE HYDRONEPHROSIS 110
Iga Nephropathy and urinary proteomics 110
MicroRNAs in glomerular diseases from pathophysiology to potential treatment target 109
null 108
AKT activation may represent the molecular link between rapamycin (RAPA) treatment and insulin-resistance in renal transplant recipients. 108
Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy 108
IL-17 expression by tubular epithelial cells in renal transplant recipients with acute antibody-mediated rejection 107
Omics studies for comprehensive understanding of immunoglobulin A nephropathy: State-of-the-art and future directions 107
Epigenetic dysregulation in neuroblastoma: A tale of miRNAs and DNA methylation 106
A bioartificial renal tubule device embedding human renal stem/progenitor cells 106
NMR-based metabolomic study of Apulian Coratina extra virgin olive oil extracted with a combined ultrasound and thermal conditioning process in an industrial setting 105
Coagulation activation induces increased NADPH-dependent reactive oxygen species (ROS) generation in haemodialysis (HD) 103
MicroRNAs in Kidney Diseases 103
IDENTIFICATION OF QUANTITATIVE TRAIT LOCI FOR DEGLYCOSYLATED IGA1 SERUM LEVELS IN FAMILIAL IGA NEPHROPATHY 102
null 101
Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy 100
An end stage kidney disease predictor based on an artificial neural networks ensemble 99
Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients 99
Multiple rare genetic variants co‐segregating with familial IgA nephropathy all act within a single immune‐related network 99
MP067 MICRORNA PROFILING USING NEXT-GENERATION SEQUENCING IN RENAL CANCER STEM CELLS: A NEW REGULATORY MECHANISM 97
Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment 96
MicroRNAs in kidney diseases: New promising biomarkers for diagnosis and monitoring 95
A proton nuclear magnetic resonance-based metabolomic approach in IgA nephropathy urinary profiles 95
null 93
BMP-2 INDUCES A PRO-FIBROTIC PHENOTYPE IN ADULT RENAL PROGENITOR CELLS THROUGH Nox4 ACTIVATION 93
Determination of hydroxytyrosol and tyrosol in human urine after intake of extra virgin olive oil produced with an ultrasounds-based technology 90
ALTERED ANTIGEN HANDLING AND INVOLVEMENT OF THE CX3CR1-FKN AXIS IN PROMOTING HEMATURIA IN IGA NEPHROPATHY PATIENTS 90
Is it time for personalized therapy in IgA nephropathy patients? 89
Low coagulation-activating dialyzer reduces progression of atherosclerosis in hemodialysis modulatig serum bone morphogenetic proteins (BMPs) 89
DRG's and cost/efficacy indicators in nephrology and dialysis. Results at a hospital division 85
Immunosuppressive agents for treating IgA nephropathy 85
Genome-wide scan identifies a copy number variable region at 3p21.1 that influences the TLR9 expression levels in IgA nephropathy patients 84
From-omics to personalized medicine in nephrology: Integration is the key 83
Patient classification and outcome prediction in IgA nephropathy 82
Altered modulation of WNT–β-catenin and PI3K/Akt pathways in IgA nephropathy 81
RARE GENETIC VARIANTS IMPLICATED IN INNATE AND ADAPTIVE IMMUNITY CO-SEGREGATE WITH FAMILIAL IGA NEPHROPATHY 81
Erratum: Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy (Nephrology Dialysis Transplantation (2009) DOI: 10.1093/ndt/gfp356) 79
miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells 78
Pharmacogenomics: A new paradigm to personalize treatments in nephrology patients 77
Randomized clinical study to evaluate the effect of personalized therapy on patients with immunoglobulin A nephropathy 74
OX40 Gene: A Potential Target for the Care of Chronic T-Cell Mediated Rejection (TCMR) 72
LINKAGE ANALYSIS DETECTES TWO ADDITIONAL REGIONS IN FAMILIAL IGA NEPHROPATHY 72
β3 adrenergic receptor as potential therapeutic target in ADPKD 72
Post-hoc analysis of a tool to predict kidney failure in patients with IgA nephropathy 71
C5b-9 generation and cytokine production in hemodialyzed patients 70
null 69
GENOME-WIDE SCAN OF COPY NUMBER VARIATIONS (CNVS) IDENTIFIES A VARIABLE REGION AT 3P21. 1 REGULATING THE TLR9 EXPRESSION IN IGA NEPHROPATHY PATIENTS 69
null 69
Epidemiology and ancestral difference 68
IgAN Genetic Risk Score in the Clinical Setting 67
Kidney and urine cell transcriptomics in IgA nephropathy and lupus nephritis: a narrative review 67
Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients 67
null 65
null 62
Serum Levels of miR-148b and Let-7b at Diagnosis May Have Important Impact in the Response to Treatment and Long-Term Outcome in IgA Nephropathy 61
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy 60
MIR-148B UPREGULATION MODULATING CORE 1, B1, 3-GALACTOSYLTRANSFERASE 1 EXPRESSION EXPLAINS THE ABNORMAL GLYCOSYLATION PROCESS OF IGA1 IN IGA NEPHROPATHY 60
Genome-wide association studies in kidney diseases: Quo Vadis 56
The authors reply 54
null 52
null 52
Searching for IgA nephropathy candidate genes: Genetic studies combined with high throughput innovative investigations 51
New directions in the pathogenesis of primary erythrocytosis in IgAN 51
null 50
Totale 10.473
Categoria #
all - tutte 46.803
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.803


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022617 33 38 8 28 22 61 14 31 44 78 90 170
2022/2023998 106 162 84 82 101 150 13 118 144 7 17 14
2023/2024365 33 47 12 34 31 115 4 20 13 10 9 37
2024/20251.673 44 46 116 56 71 116 181 156 53 90 257 487
2025/20264.125 562 163 205 417 491 244 408 112 496 415 176 436
2026/2027103 103 0 0 0 0 0 0 0 0 0 0 0
Totale 10.893